<DOC>
	<DOC>NCT00704782</DOC>
	<brief_summary>The purpose of this study is to assess the safety and efficacy of Dimebon in combination with donepezil (Aricept) in the treatment of Alzheimer's disease.</brief_summary>
	<brief_title>Study of Combination Therapy With Dimebon and Donepezil (Aricept) in Patients With Alzheimer's Disease</brief_title>
	<detailed_description />
	<mesh_term>Alzheimer Disease</mesh_term>
	<mesh_term>Donepezil</mesh_term>
	<criteria>Alzheimer's disease On donepezil (Aricept) Caregiver who cares for the patient at least 5 days per week Unstable medical illnesses or significant hepatic or renal disease Other primary psychiatric or neurological disorders</criteria>
	<gender>All</gender>
	<minimum_age>50 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2015</verification_date>
</DOC>